1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Kohno, T.
Kobayashi, K.
Maeda, T.
Sato, K.
Takashima, A.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
35
16094
16104
10.1021/bi961598j
8973180
Three-dimensional structures of the amyloid beta peptide (25-35) in membrane-mimicking environment.
1996
10.2210/pdb1qcm/pdb
pdb_00001qcm
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1061.278
AMYLOID BETA PEPTIDE
RESIDUES 25 - 35
1
nat
polymer
no
no
GSNKGAIIGLM
GSNKGAIIGLM
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
human
Homo
sample
9606
Homo sapiens
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1997-07-07
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-03-02
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
Y
BNL
1996-07-19
REL
20
GLY
1
n
1
GLY
1
A
SER
2
n
2
SER
2
A
ASN
3
n
3
ASN
3
A
LYS
4
n
4
LYS
4
A
GLY
5
n
5
GLY
5
A
ALA
6
n
6
ALA
6
A
ILE
7
n
7
ILE
7
A
ILE
8
n
8
ILE
8
A
GLY
9
n
9
GLY
9
A
LEU
10
n
10
LEU
10
A
MET
11
n
11
MET
11
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
SER
2
-168.58
47.17
2
A
SER
2
-63.04
-169.67
3
A
SER
2
-171.62
58.95
3
A
ASN
3
-170.89
49.18
4
A
SER
2
75.49
80.65
4
A
ASN
3
78.47
43.45
5
A
SER
2
62.94
127.41
5
A
ASN
3
-172.36
54.04
7
A
SER
2
75.53
141.65
7
A
ASN
3
-156.85
51.36
9
A
ASN
3
-147.11
52.06
10
A
ASN
3
72.76
54.84
11
A
ASN
3
-163.83
49.85
15
A
SER
2
-118.45
72.90
15
A
ASN
3
167.07
57.67
16
A
ASN
3
-143.81
44.91
17
A
ASN
3
73.33
55.92
19
A
ASN
3
175.34
51.26
20
A
ASN
3
-167.52
53.67
AMYLOID BETA PEPTIDE (25-35), NMR, 20 STRUCTURES
1
Y
N
A
LYS
4
A
LYS
4
HELX_P
A
ILE
7
A
ILE
7
1
1
4
AMYLOID
GLYCOPROTEIN, AMYLOID, ALZHEIMER'S DISEASE, DOWN'S SYNDROME, NEURONE, TRANSMEMBRANE, ALTERNATIVE SPLICING, SERINE PROTEASE INHIBITOR, DISEASE MUTATION
A4_HUMAN
UNP
1
1
P05067
MLPGLALLLLAAWTARALEVPTDGNAGLLAEPQIAMFCGRLNMHMNVQNGKWDSDPSGTKTCIDTKEGILQYCQEVYPEL
QITNVVEANQPVTIQNWCKRGRKQCKTHPHFVIPYRCLVGEFVSDALLVPDKCKFLHQERMDVCETHLHWHTVAKETCSE
KSTNLHDYGMLLPCGIDKFRGVEFVCCPLAEESDNVDSADAEEDDSDVWWGGADTDYADGSEDKVVEVAEEEEVAEVEEE
EADDDEDDEDGDEVEEEAEEPYEEATERTTSIATTTTTTTESVEEVVREVCSEQAETGPCRAMISRWYFDVTEGKCAPFF
YGGCGGNRNNFDTEEYCMAVCGSAMSQSLLKTTQEPLARDPVKLPTTAASTPDAVDKYLETPGDENEHAHFQKAKERLEA
KHRERMSQVMREWEEAERQAKNLPKADKKAVIQHFQEKVESLEQEAANERQQLVETHMARVEAMLNDRRRLALENYITAL
QAVPPRPRHVFNMLKKYVRAEQKDRQHTLKHFEHVRMVDPKKAAQIRSQVMTHLRVIYERMNQSLSLLYNVPAVAEEIQD
EVDELLQKEQNYSDDVLANMISEPRISYGNDALMPSLTETKTTVELLPVNGEFSLDDLQPWHSFGADSVPANTENEVEPV
DARPAADRGLTTRPGSGLTNIKTEEISEVKMDAEFRHDSGYEVHHQKLVFFAEDVGSNKGAIIGLMVGGVVIATVIVITL
VMLKKKQYTSIHHGVVEVDAAVTPEERHLSKMQQNGYENPTYKFFEQMQN
696
706
1QCM
1
11
P05067
A
1
1
11
1
P 1